TNFRSF9 and neoplasm: CD137 has been established by our group and others as an accurate marker of antigen-specific activation45,46 and its expression is linked with a functional tumor-infiltrating lymphocyte profile,47 making it particularly relevant in the context of advanced dyplasia and cancer driven by HPV infection.